viewKromek Group PLC

Kromek Group increase revenues and land £1.2mln Innovate UK funding to design a system virus test

Kromek Group PLC's (LON:KMK) Dr Arnab Basu speaks to Proactive London's Katie Pilbeam about their results for the six months to October 31, 2020.

For the first half, the company reported an adjusted (EBITDA) loss of £0.9mln compared to a £0.6mln loss in the prior year, while revenues moved to £4.6mln from £5.3mln.

Arnab also details a £1.2mln programme, funded by Innovate UK, to design a system to detect airborne viruses, including coronavirus (COVID-19).

The solution can be used at airports, hospitals, retail outlets and entertainment venues, with the initial focus of the programme being to develop a system to rapidly test for the presence of SARS-CoV-2, the virus that causes COVID-19.

Quick facts: Kromek Group PLC

Price: 17.4195 GBX

Market: AIM
Market Cap: £60.42 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Kromek Group PLC named herein, including the promotion by the Company of Kromek Group PLC in any Content on the Site, the Company receives from...


Kromek Group set to 'accelerate commercialisation' after £13mln raise

Kromek Group PLC (LON:KMK) CEO Arnab Basu talks to Proactive London's Katie Pilbeam about the plans for their £13mln raise through a firm placing, directors' subscription and open offer at 15p per share. He explains how the money will be spent to increase the rate of commercialisation, sales...

1 week, 4 days ago

2 min read